Tighter Curbs Detailed for Acne Drugs
- Share via
The acne drug Accutane and its generic versions will face tighter prescription controls to prevent harm to fetuses, federal health regulators said.
The measures include a new joint database shared by all manufacturers of the drug to monitor patients, doctors and pharmacies, the Food and Drug Administration said.
Pregnant women are not to use Accutane, or isotretinoin because it can cause fetuses to die or develop birth defects. But FDA officials are concerned about women who get pregnant while taking the drug.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
